Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity ; volume:24 ; number:1 ; day:24 ; month:5 ; year:2024 ; pages:1-8 ; date:12.2024
BMC ophthalmology ; 24, Heft 1 (24.5.2024), 1-8, 12.2024
- Urheber
-
Minturn, Robert
Hartigan, Kelly
Vegunta, Sravanthi
Boente, Charline
Golzarri-Arroyo, Lilian
Hynes, Elizabeth
Laughlin, Elleen
Haider, Kathryn
Kua, Kok Lim
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12886-024-03483-w
- URN
-
urn:nbn:de:101:1-2408051106437.771374889094
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Minturn, Robert
- Hartigan, Kelly
- Vegunta, Sravanthi
- Boente, Charline
- Golzarri-Arroyo, Lilian
- Hynes, Elizabeth
- Laughlin, Elleen
- Haider, Kathryn
- Kua, Kok Lim
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection
Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease
Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection
Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease
Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
Evaluating the causes of retinopathy of prematurity relapse following intravitreal bevacizumab injection
Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity
Ocular complications following intravitreal bevacizumab injection for retinopathy of prematurity and assessment of risk factors
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Growth and neurodevelopmental status in patients with retinopathy of prematurity treated with intravitreal bevacizumab: a case–control study
A lower dose of intravitreal conbercept effectively treats retinopathy of prematurity
Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity
Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease